Would you get a one-time genetic modification such that you'd never have to take a GLP-1 drug for weight loss ever again?

Shares of telehealth company Hims & Hers Health (NYSE:HIMS) jumped 4.1% in the morning session after the company announced ...

GLP-1 drugs alter taste perceptions, challenging food makers to adapt by enhancing umami flavours, balancing sweetness, and ...

The Hims & Hers wellness platform announced Wednesday it will soon offer a generic version of the weight loss drug semaglutide in Canada as Novo Nordisk's patent on its branded version, known as ...

A little over a year after celebrating its 30th anniversary in China with a major production upgrade, Novo Nordisk is back ...

A study in Diabetes, Obesity and Metabolism has identified certain characteristics that might influence people's weight loss ...

For many, the high cost of the pill means stopping is a matter of 'when,' not 'if.' Endocrinologists reveal the crucial steps ...

Technology will soon make it possible to develop cheap, widely accessible psychoactive substances that are not harmful in the ...

We're going to take a look at how weight-loss surgery completely changed Kelly Osbourne's life, as well as her ups and downs ... in weight, that is!

Does using Ozempic cause brain fog? It depends on who you ask. This article takes a closer look at what’s going on with ...

Some online pharmacies sell semaglutide and tirzepatide that are ineffective, unsafe, or an outright scam. Here’s how to find ...

Hims & Hers, the high-flying online health company that rapidly grew from a buzzy startup selling Viagra to a multibillion-dollar business, had a hard month.